Skip to main content

Indicators of Functional Disability by Receipt of Disability Benefits Among Individuals With Systemic Lupus Erythematosus.

Publication ,  Journal Article
Plantinga, LC; Roberts, ET; Hoge, C; Pearce, BD; Bowling, CB
Published in: J Rheumatol
May 1, 2025

OBJECTIVE: We estimated the prevalence of potential functional disability among those with systemic lupus erythematosus (SLE), by receipt of disability benefits. METHODS: Participants (N = 443, mean age 46.2 years, 91.7% women, 82.6% Black) were recruited from a population-based SLE cohort. Indicators of potential disability included functioning impairments (Short Physical Performance Battery score ≤ 10; age-corrected National Institutes of Health Toolbox Cognition Battery composite score for fluid cognition < 77.5 [1.5 SD below the mean]); activity limitations (physical functioning T-scores < 35 [1.5 SD below the mean]); at least some difficulty performing ≥ 1 of the instrumental activities of daily living (IADLs) or basic activities of daily living (BADLs); and participation restrictions (any vs no reported effect of health on ability to work; restricted community mobility). We performed multivariable logistic regression models predicting potential disability indicators by self-reported receipt of disability benefits and then obtained adjusted prevalence estimates using postestimation margins. RESULTS: Those who reported receiving disability benefits (45.6%) vs not (54.4%) were more likely to have impairments in functioning (physical performance [71.3% vs 50%, P < 0.001]; fluid cognition [35.4% vs 19.2%, P = 0.01]), limitations in activities (self-reported physical limitations [26.7% vs 7.5%, P < 0.001]; IADLs [73.1% vs 42.9%, P < 0.001]; BADLs [60.6% vs 30.8%, P < 0.001]), and restrictions in participation (work [77.8% vs 60.6%, P = 0.09]; community mobility [43.1% vs 22%, P < 0.001]). These associations were not changed with adjustment for personal and SLE factors. CONCLUSION: Receipt of disability benefits may be an incomplete marker of functioning. A substantial proportion of those not receiving benefits have impairments, limitations, and restrictions that should be addressed.

Duke Scholars

Published In

J Rheumatol

DOI

EISSN

1499-2752

Publication Date

May 1, 2025

Volume

52

Issue

5

Start / End Page

479 / 488

Location

Canada

Related Subject Headings

  • Prevalence
  • Persons with Disabilities
  • Middle Aged
  • Male
  • Lupus Erythematosus, Systemic
  • Humans
  • Female
  • Disability Evaluation
  • Arthritis & Rheumatology
  • Adult
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Plantinga, L. C., Roberts, E. T., Hoge, C., Pearce, B. D., & Bowling, C. B. (2025). Indicators of Functional Disability by Receipt of Disability Benefits Among Individuals With Systemic Lupus Erythematosus. J Rheumatol, 52(5), 479–488. https://doi.org/10.3899/jrheum.2024-0961
Plantinga, Laura C., Eric T. Roberts, Courtney Hoge, Brad D. Pearce, and C Barrett Bowling. “Indicators of Functional Disability by Receipt of Disability Benefits Among Individuals With Systemic Lupus Erythematosus.J Rheumatol 52, no. 5 (May 1, 2025): 479–88. https://doi.org/10.3899/jrheum.2024-0961.
Plantinga LC, Roberts ET, Hoge C, Pearce BD, Bowling CB. Indicators of Functional Disability by Receipt of Disability Benefits Among Individuals With Systemic Lupus Erythematosus. J Rheumatol. 2025 May 1;52(5):479–88.
Plantinga, Laura C., et al. “Indicators of Functional Disability by Receipt of Disability Benefits Among Individuals With Systemic Lupus Erythematosus.J Rheumatol, vol. 52, no. 5, May 2025, pp. 479–88. Pubmed, doi:10.3899/jrheum.2024-0961.
Plantinga LC, Roberts ET, Hoge C, Pearce BD, Bowling CB. Indicators of Functional Disability by Receipt of Disability Benefits Among Individuals With Systemic Lupus Erythematosus. J Rheumatol. 2025 May 1;52(5):479–488.

Published In

J Rheumatol

DOI

EISSN

1499-2752

Publication Date

May 1, 2025

Volume

52

Issue

5

Start / End Page

479 / 488

Location

Canada

Related Subject Headings

  • Prevalence
  • Persons with Disabilities
  • Middle Aged
  • Male
  • Lupus Erythematosus, Systemic
  • Humans
  • Female
  • Disability Evaluation
  • Arthritis & Rheumatology
  • Adult